Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis.
Crowley BM, Boshoff HI, Boving A, Tan VY, Zhu J, Hoyt F, Miller RR, Ehrhart J, Boyce CW, Young K, Nantermet PG, Su J, Yang L, Painter RE, Corcoran EB, Hoar JL, Oh S, Holtzman DL, Levi M, Anderson A, Otieno MA, Zimmerman M, Kaya F, Massoudi LM, Ramey ME, Bauman AA, Lenaerts AJ, Roberston GT, Dartois V, Wells CD, Barry CE 3rd, Olsen DB.
Crowley BM, et al. Among authors: yang l.
Nat Med. 2026 Feb;32(2):553-560. doi: 10.1038/s41591-025-04164-x. Epub 2026 Jan 13.
Nat Med. 2026.
PMID: 41530381
Free PMC article.